TIM-3 expression in breast cancer

by Samantha Burugu, Dongxia Gao, Samuel Leung, Stephen K. Chia, Torsten O. Nielsen
Published 2018-11-01

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors

by Leah K. Lambert, Lynda G. Balneaves, A. Fuchsia Howard, Stephen K. Chia, Carolyn C. Gotay
Published 2018-07-01

Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG...

by Christina L. Addison, Gregory R. Pond, Brandy Cochrane, Huijun Zhao, Stephen K. Chia, Mark N. Levine, Mark Clemons
Published 2015-06-01

A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER...

by Stephen K. Chia, Susan L. Ellard, Mihaela Mates, Stephen Welch, Catalin Mihalcioiu, Wilson H. Miller, Karen Gelmon, Caroline Lohrisch, Vikaash Kumar, Sara Taylor, Linda Hagerman, Rachel Goodwin, Tao Wang, Shingo Sakashita, Ming S. Tsao, Elizabeth Eisenhauer, Penelope Bradbury
Published 2017-05-01